Cyclo3pss FCF per Share
The Free Cash Flow per Share of Cyclo3pss (CYPS) as of Oct 28, 2026 is -0.02 USD.
Get this data via API
Financial Data API
FCF per Share
-0.02USD
Last updated:
Free Cash Flow per Share of Cyclo3pss is 2002 -0.02 USD. Free Cash Flow per Share of Cyclo3pss was 2001 - USD. It decreases by % lower compared to the previous year.
The Cyclo3pss FCF per Share history
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.02USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cyclo3pss Stock analysis
What does Cyclo3pss do? Cyclo3pss Corp licenses its proprietary technologies to partners with suitable resources and infrastructure to commercialize specific products. The company's principal technology addresses food safety, healthcare sanitizing, and laundry disinfection. Its products include Ster-O3-Zone, a medical sterilizer for the medical and pharmaceutical industries, Eco Wash, laundry equipment for hotels, nursing homes, and institutional markets, and Eco Pure, which applies ozone to sanitize turkey, beef, and pork carcasses as well as brine in cured meat products. Partners with existing infrastructure in these sectors purchase the licensing rights to deploy these technologies.
Ster-O3-Zone targets medical and pharmaceutical markets, while Eco Wash serves institutional clients like hotels and nursing homes. Eco Pure focuses on meat processing applications, including carcass sanitization and brine treatment. The company generates revenue through licensing agreements, enabling partners to integrate these technologies into their existing operations without developing them in-house.
The firm's licensing model allows partners to leverage Cyclo3pss Corp's proprietary technology in their respective markets. Partners include entities with resources to commercialize the technologies, such as those in healthcare, food processing, and institutional services. Cyclo3pss Corp does not sell products directly but earns income by granting licenses to these partners for specific applications. Cyclo3pss is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Cyclo3pss stock
Free Cash Flow per Share of Cyclo3pss is -0.02 USD in 2002.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Cyclo3pss since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Cyclo3pss
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Cyclo3pss
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth